Picard Medical, Inc. (PMI)

CIK 0002030617 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
FY-2025
Latest Q1-2026 8-K (2026-05-21) · 99.1  |  8-K (2026-04-22) · 99.1
Latest FY-2025 8-K (2026-03-25) · 99.1
Q3-2025 8-K (2025-11-14) · 99.1
Q2-2025 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Document and Entity Information
Statements
Consolidated Balance Sheets
Unaudited Condensed Consolidated Balance Sheets
—
Consolidated Balance Sheets (P)
Unaudited Condensed Consolidated Balance Sheets (P)
—
Consolidated Statements of Operations and Comprehensive Loss
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Changes In Temporary Equity and Stockholders' Deficit(unaudited)
—
Consolidated Statements of Changes In Temporary Equity and Stockholders' Equity (deficit)
—
Unaudited Consolidated Statements of Changes In Temporary Equity and Stockholders' Deficit
—
Unaudited Consolidated Statements of Changes In Temporary Equity and Stockholders' Equity (deficit)
—
Consolidated Statements of Cash Flows
Unaudited Condensed Consolidated Statements of Cash Flows
—
Notes
Award Timing Disclosure
—
Certain Balance Sheet Components
—
Commitments and Contingencies
—
Concentrations
—
Convertible Notes
—
Cybersecurity Risk Management and Strategy Disclosure
—
Description of Business, Basis of Presentation and Managements Plan
—
Fair Value of Financial Instruments
—
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Net Loss Per Share
—
Note 1
Note 10
Note 11
Note 12
Note 13
Note 14
Note 15
Note 2
Note 3
Note 4
Note 5
Note 6
Note 7
Note 8
Note 9
Pay Vs Performance Disclosure
—
Related Party Transactions
—
Retirement Plans
—
Revenue
—
Share Based Compensation
—
Subsequent Events
—
Summary of Significant Accounting Policies
—
Temporary Equity and Stockholders Deficit
—